Skip to main content
ELANElanco Animal Health IncorporatSell4.8·$24.27+1.31%
ELAN · Why this verdict

Why Elanco Animal Health Incorporat (ELAN) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score4.8/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

The company has delivered four consecutive quarterly earnings beats averaging a 25% positive surprise, and technical indicators confirm a constructive breakout — golden cross, RSI 60, MACD bullish — but the current price offers only 6.7% upside against materially larger downside, and the reward-to-risk ratio at approximately 0.5-to-1 falls well short of the minimum threshold needed to justify entering a new position despite the otherwise attractive fundamental signals.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

The company has beaten analyst consensus EPS estimates in each of the last four quarters, with an average positive surprise of roughly 25%, pointing to a pattern of expectations being set below what the business can deliver.

Stable
Earnings
Expectation
Earnings beats continue for at least 2 more consecutive quarters with positive EPS surprise exceeding 10%.

CounterThe growth profile remains below average and business quality screens below the sector median — a beat streak built on low consensus estimates can reverse quickly if analysts raise their bars following four successive positive surprises.

The stock has established a golden cross, trades above all key moving averages, carries an RSI of 60, and shows a bullish MACD alongside rising on-balance volume — a technically constructive configuration that supports continuation of the recent uptrend.

Stable
V9
Expectation
Stock remains above the 200-day moving average for at least 3 consecutive months with RSI sustaining above 55.

CounterThe stock's beta exceeds 1.7, meaning it amplifies broad market moves in both directions — a constructive chart pattern in a high-beta name can reverse sharply on any sector or macro rotation, and elevated implied volatility of 86% signals the market is pricing in substantial future price swings.

Short interest stands at 11% of float, indicating meaningful institutional skepticism about the stock's near-term prospects — an overhang that can suppress price moves or amplify reversals in either direction.

Stable
Risk breakdown
Expectation
If this risk resolves, short interest would fall below 5% of float over the next 2 quarters.

CounterElevated short interest combined with strong earnings beats can fuel sharp upside if shorts are forced to cover — the same overhang that creates risk also embeds a potential catalyst that could accelerate gains on the next positive earnings event.

With only 6.7% upside to the analyst price target against 15% of downside, the reward-to-risk ratio sits at approximately 0.5-to-1 — well below the minimum threshold for a new position, regardless of the quality of the underlying fundamental and technical signals.

Stable
Price targets
Expectation
If the risk/reward improves, upside to target would expand beyond 15% and the reward-to-risk ratio would exceed 1.5.

CounterAnalyst targets can be revised upward following continued earnings beats — if two more strong beats arrive, consensus targets may step up enough to widen the upside window materially from the current 6.7%.

Per-dimension breakdown

Value

5.3/10data confidence 83%
ComponentSub-score
P/S8.7
EV/EBITDA2.2
Fwd P/E6.4
PEG3.1
Analyst target6.0
  • Forward P/E: 20.2x
  • PEG: 4.04

Quality

4.6/10data confidence 100%
ComponentSub-score
ROE0.0
ROA1.0
Gross margin7.0
Op margin4.9
Net margin0.0
Current ratio7.5
FCF quality6.0
Moat6.5
Piotroski F8.9
  • FCF-positive but moderate margins (FCF margin 14%, FCF yield 5.8%)
  • Strong Piotroski F-Score: 8/9

Growth

3.1/10data confidence 67%
ComponentSub-score
Rev growth6.2
EPS growth0.0

Momentum

3.8/10data confidence 100%
ComponentSub-score
RSI5.5
MACD3.5
OBV1.0
MA position9.0
Volume0.0
  • Volume distribution (falling OBV)
  • Above 200-day MA

Sentiment

7.4/10data confidence 100%
ComponentSub-score
Analyst rating8.6
Price target8.0
erm sentiment5.1
  • Analyst upside: 23%

Insider

5.0/10data confidence 50%
ComponentSub-score
materiality5.0
holder change5.0
  • Negligible insider buying — $199,781 (0.002% of mkt cap)

Peer rank

3.5/10data confidence 80%
ComponentSub-score
value rank5.0
quality rank1.5
growth rank7.4

Technical

5.2/10data confidence 100%
ComponentSub-score
bollinger2.9
support resistance5.4
52w position7.6
gap5.0

Risk (lower is worse)

5.7/10data confidence 100%
ComponentSub-score
short interest4.7
days to cover6.2
volatility2.2
put call10.0
implied vol3.9
max pain risk7.0
beta4.3
debt equity7.0

Catalyst

7.5/10data confidence 100%
ComponentSub-score
erm5.0
earnings history10.0
earnings timing5.0
surprise avg10.0
  • Perfect beat streak: 4Q

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (6)
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:42d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
  • MOMENTUM:3.8<4.5
  • ASYMMETRY:0.8<1.5@spot
Warning (0)

none

Reward-to-Risk
0.81
Upside
+6.7%
Downside
8.3%
Sizing output
AVOID

SetupUNKNOWN No clear chart pattern; technical signals are mixed

EdgeNO_EDGE No clear edge identified

SuitabilityAGGRESSIVE Beta 1.70>1.3

Investment implication

The F-path SELL output reflects an overall score of 4.8 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Catalyst at 7.5) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( MOMENTUM:3.8<4.5, ASYMMETRY:0.8<1.5@spot) reinforce the read. Current asymmetry R:R is 0.81 — supplementary context, not the trigger for this path.

The strongest dimensions are Catalyst at 7.5, Sentiment at 7.4, and Risk (lower is worse) at 5.7; the weakest are Growth at 3.1, Peer rank at 3.5, and Momentum at 3.8. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of 0.81 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1The company has beaten analyst consensus EPS estimates in each of the last four quarters, with an average positive surprise of roughly 25%, pointing to a pattern of expectations being set below what the business can deliver.

    Trip ifAverage EPS surprise falls below 0% for 2 consecutive quarters.

  • P2The stock has established a golden cross, trades above all key moving averages, carries an RSI of 60, and shows a bullish MACD alongside rising on-balance volume — a technically constructive configuration that supports continuation of the recent uptrend.

    Trip ifStock price falls below the 200-day moving average and RSI drops below 45 for 4 consecutive weeks.

  • P3Short interest stands at 11% of float, indicating meaningful institutional skepticism about the stock's near-term prospects — an overhang that can suppress price moves or amplify reversals in either direction.

    Trip ifShort interest falls below 5% of float for 2 consecutive months.

  • P4With only 6.7% upside to the analyst price target against 15% of downside, the reward-to-risk ratio sits at approximately 0.5-to-1 — well below the minimum threshold for a new position, regardless of the quality of the underlying fundamental and technical signals.

    Trip ifUpside to analyst price target expands beyond 15% with a reward-to-risk ratio exceeding 1.5.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks ELAN Why this verdict